Trial intelligence / Profile preview

Pathophysiology of Cheyne-Stokes respiration: lowering pulmonary capillary wedge pressure

DRKS00000467Phase 2Completed

Sponsor
Heart and Diabetes Center North Rhine-Westphalia
Start
Jun 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Cheyne-Stokes respiration (CSR) and heart failure (HF) comparing Perlinganit arm, Ventavis arm and Placebo arm (3 arms). Started Jun 2010; status: completed.

02

Drugs

Nitro Giloprost
03

Conditions

Cheyne-Stokes respiration (CSR)heart failure (HF)

Beyond the preview

Go deeper on DRKS00000467.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00000467.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call